Exploring your options for Motor Neuron Disease (ALS) in India? Ginger Healthcare brings together a carefully chosen panel of reputed neurologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Motor Neuron Disease (ALS). Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Motor Neuron Disease (ALS). These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Motor neuron disease (MND), most commonly known as amyotrophic lateral sclerosis (ALS), is a progressive neurological condition in which the nerve cells responsible for controlling voluntary muscle movement gradually degenerate and die. This leads to increasing weakness, muscle wasting, and — over time — difficulty with movement, speech, swallowing, and breathing. While there is currently no cure, modern MND care has advanced considerably: disease-modifying medications can modestly slow progression in some patients, and a wide range of supportive therapies can preserve function, manage symptoms, and protect quality of life for years. Care is multidisciplinary, typically involving neurologists, respiratory specialists, speech therapists, dietitians, physiotherapists, and palliative care teams working together. The right approach for any individual depends on disease type, stage, rate of progression, and personal priorities.
A comprehensive specialist assessment followed by disease-modifying medication (such as riluzole) and a coordinated care plan from a multidisciplinary MND team — the cornerstone of MND management at any stage.
Estimated cost: ~$500 – $1,000
Typical tests: EMG and nerve conduction studies (if not recent or repeat needed), Pulmonary function test — forced vital capacity (FVC) and SNIP, Overnight pulse oximetry, Swallowing assessment (video fluoroscopy or fiberoptic endoscopy), CBC, liver function tests, kidney function tests, Thyroid function tests, Neuroimaging review (MRI brain/spine if not done or outdated), ALSFRS-R functional scale scoring. Done in India before admission.
Estimated cost in India: $2,500 – $5,000
Treatment duration in India: ~2 weeks (~7 hospital visit days across the full span)
Specialist setup and titration of non-invasive ventilation (NIV/BiPAP) for patients whose breathing muscles are weakening — this significantly improves quality of life and, in many patients, extends survival.
Estimated cost: ~$500 – $1,000
Typical tests: Forced vital capacity (FVC) and SNIP measurement, Overnight pulse oximetry with CO2 monitoring, Arterial blood gas (ABG) analysis, Chest X-ray, CBC and electrolyte panel, Pulmonary function test (full spirometry), ECG. Done in India before admission.
Estimated cost in India: $3,000 – $6,000
Treatment duration in India: ~10 days (~5 hospital visit days across the full span)
Minimally invasive placement of a feeding tube directly into the stomach for patients whose swallowing is becoming unsafe or calorie intake is falling — done while breathing function is still relatively preserved for lower procedural risk.
Estimated cost: ~$500 – $1,000
Typical tests: Swallowing assessment (video fluoroscopy or fiberoptic endoscopy), Forced vital capacity (FVC) — anaesthetic risk stratification, CBC, coagulation screen (PT/INR), liver and kidney function, Blood glucose and electrolytes, Chest X-ray, ECG, Anaesthesia fitness evaluation. Done in India before admission.
Estimated cost in India: $3,500 – $7,000
Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: ~3 days
Recovery period (outside hospital): ~7 days recommended
Total stay: approx 12 days
A structured inpatient rehabilitation programme combining physiotherapy, occupational therapy, speech therapy, and psychological support to maximise function, adapt daily activities, and train caregivers — suitable for patients at any stage.
Estimated cost: ~$500 – $1,000
Typical tests: ALSFRS-R scoring and functional baseline assessment, Pulmonary function test (FVC, SNIP), Swallowing screening, CBC, liver function, kidney function, blood glucose, Nutritional markers — albumin, pre-albumin, BMI, Overnight pulse oximetry (if respiratory symptoms present), Cognitive and mood screening (MoCA or equivalent). Done in India before admission.
Estimated cost in India: $4,000 – $12,000
Treatment duration in India: ~3 weeks (~14 hospital visit days across the full span)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
